12.1 Product Benchmarking 12.1.1 Instruments 12.1.2 Consumables
12.1.2.1 Pregnancy Kits 12.1.3 IVD Reagents
12.2 Competitor Benchmarking 12.2.1 Clinical Chemistry Products 12.2.2 HIV Simple Assays / Rapid Diagnostics Tests ( RDTs ) 12.2.3 HIV Enzyme Immunoassays ( EIAs ) 12.2.4 HCV Enzyme Immunoassays ( EIA ) 12.2.5 CD4 Enumeration Technologies 12.2.6 HIV Quantitative Nucleic Acid Testing Technologies
12.2.7 HIV Qualitative Nucleic Acid Testing Technologies for HIV Diagnosis , Including Early Infant Diagnosis
12.2.8 Haematology Analyzers
13 Competitive Landscape
13.1 Market Share Analysis 13.2 Growth Share Matrix 13.3 Comprehensive Competitive Index 13.4 Supply Chain 13.5 Value Chain
14 Company Profile
14.1 F . Hoffmann-La Roche AG 14.1.1 Overview 14.1.2 Financials
14.1.2.1 Financial Summary 14.1.3 SWOT Analysis
14.2 Danaher Corporation 14.2.1 Overview 14.2.2 Financials
14.2.2.1 Financial Summary 14.2.3 SWOT Analysis
14.3 Agilent Technologies 14.3.1 Overview
14.3.2 Financials 14.3.2.1 Financial Summary
14.3.3 SWOT Analysis 14.4 Novartis International AG 14.4.1 Overview 14.4.2 Financial
14.4.2.1 Financial Summary 14.4.3 SWOT Analysis
14.5 Illumina , Inc .
� sales @ bisresearch . com www . bisresearch . com 12